News
JNJ
155.50
+1.56%
2.39
Which Is A Better Pick: JNJ Stock Or ABBV Stock?
NASDAQ · 12h ago
J&J : Canada Approves CARVYKTI For Relapsed Or Refractory Multiple Myeloma After 1-3 Prior Therapies
NASDAQ · 13h ago
Zevra Niemann-Pick disease type C drug Miplyffa now available
Seeking Alpha · 15h ago
Eli Lilly Stock: Unexpected Developments (Rating Downgrade)
Seeking Alpha · 16h ago
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are Refractory To Lenalidomide
Benzinga · 17h ago
Merck Stock Trades Near 52-Week Low: What's Next for Investors?
NASDAQ · 18h ago
Optimism over global healthcare sector rises: Jefferies
Seeking Alpha · 19h ago
Price Over Earnings Overview: Johnson & Johnson
Benzinga · 1d ago
Johnson & Johnson’s Promising Pharmaceutical Developments Justify Buy Rating
TipRanks · 1d ago
Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy
Seeking Alpha · 1d ago
J&J Loses Around $24B in a Month: How to Play the Stock?
NASDAQ · 1d ago
Dr. Oz Goes from TV to the Most Important Job in Healthcare. Here's What CMS Actually Does.
Barron‘s · 1d ago
U.S. CDC Says Flu, Covid-19, RSV Illnesses Are At Low Levels Right Now Overall In U.S., But We Expect Them To Increase In Coming Weeks; Expects Hospitalizations For Flu And Covid-19 To Start Increasing In Coming Weeks
Benzinga · 1d ago
Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz
TipRanks · 1d ago
Reported Earlier, "J&J, Merck Cut Jobs in China As Local Competition Takes Toll" - BNN Bloomberg
Benzinga · 1d ago
Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports
TipRanks · 1d ago
XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)
Seeking Alpha · 2d ago
Pre-Market Most Active for Nov 20, 2024 : NVDA, NIO, TSLL, RZLV, TGT, SMCI, MSTR, JNJ, IBIT, SO, ZIM, PLTR
NASDAQ · 2d ago
My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys
Seeking Alpha · 2d ago
BlackRock Advantage Global Fund Q3 2024 Commentary
Seeking Alpha · 2d ago
More
Webull provides a variety of real-time JNJ stock news. You can receive the latest news about Johnson & Johnson through multiple platforms. This information may help you make smarter investment decisions.
About JNJ
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).